CAT and Insulin resistance: Thiazolidinediones (TZD) counteract insulin resistance through its binding to PPARγ, which activates the transcription of antioxidant-associated genes, including superoxide Dismutase1 (SOD) and catalase (CAT) (Khoo et al., 2013).